Company Registration No. 15266451 (England and Wales)
Cardiac ANB Limited
Unaudited accounts
for the period from 7 November 2023 to 30 November 2024
Cardiac ANB Limited
Unaudited accounts
Contents
Cardiac ANB Limited
Statement of financial position
as at 30 November 2024
Cash at bank and in hand
7,675
Creditors: amounts falling due within one year
(4,292)
Profit and loss account
3,493
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 21 July 2025 and were signed on its behalf by
A Boulemden
Director
Company Registration No. 15266451
Cardiac ANB Limited
Notes to the Accounts
for the period from 7 November 2023 to 30 November 2024
Cardiac ANB Limited is a private company, limited by shares, registered in England and Wales, registration number 15266451. The registered office is 8 Marella Close, Edwalton, Nottingham, Nottinghamshire, NG12 4LJ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
Amounts falling due within one year
Cardiac ANB Limited
Notes to the Accounts
for the period from 7 November 2023 to 30 November 2024
5
Creditors: amounts falling due within one year
2024
Taxes and social security
2,288
Allotted, called up and fully paid:
2 Ordinary shares of £1 each
2
Shares issued during the period:
2 Ordinary shares of £1 each
2
7
Average number of employees
During the period the average number of employees was 1.